Interstitial prostatism model animal

Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C800S008000, C800S009000

Reexamination Certificate

active

07417175

ABSTRACT:
The present invention provides an animal model for prostatic stromal hyperplasia, and a method for screening for a substance effective for preventing/treating human benign prostatic hyperplasia using the animal model. The animal model for prostatic stromal hyperplasia is produced by implanting the fetal urogenital sinus of a non-human animal under the skin or beneath the prostatic capsule of a non-human animal belonging to the species of the same as or different from the animal. A substance effective for preventing/treating human benign prostatic hyperplasia can be screened by administering a test substance to the animal model and measuring the preventive or therapeutic effect of the test substance upon the implanted tissue (fetal urogenital sinus or tissue derived therefrom).

REFERENCES:
Gojo et al. (2000) Gene Therapy and Transplantation. Transplantation. 69:1995-1999.
Chung et al. (1984) Tissue Interactions and Prostatic Growth. I. Induction of Adult Mouse Prostatic Hyperplasia by Fetal Urogenital Sinus Implants. 31:155-163.
Goto et al. (2000) Gene Therapy and Transplantation. Transplantation. vol. 69, pp. 1995-1999.
Jonathan P. Jarow and John T. Isaacs, “Prostatic Growth Effects of Rat Urogenital Sinus and Human Prostatic Tissue in the Rat,” The Prostate 14, pp. 301-308, 1989.
Deland W.K. Chung, et al., “Tissue Interactions and Prostatic Growth: A New Mouse Model for Prostatic Hyperplasia,” Annals New York Academy of Sciences, vol. 438, pp. 394-404, 1984.
Leland W.K. Chung and Gerald R. Cunha, “Stromal-Epithelial Interactions: II. Regulation of Prostatic Growth by Embryonic Urogenital Sinus Mesenchyme,” The Prostate 4, pp. 503-511, 1983.
Yoshiki Sugimura, et al., “Regional Differences in the Inductive Activity of the Mesenchyme of the Embryonic Mouse Urogenital Sinus,” The Prostate 7, pp. 253-260, 1985.
John E. McNeal, “Origin and Evolution of Benign Prostatic Enlargement,” Investigative Urology, vol. 15, No. 4, pp. 340-345, 1978.
Thompson, T.C. (2000) “Mouse prostate reconstitution model system: a series of in vivo and in vitro models for benign and malignant prostatic disease” The Prostate 43:248-254.
Bostwick, D.G. (2000) “Prostatic intraepithelial neoplasia: animal models 2000” The Prostate 43:286-294.
Sharma, P. (1999) “Mouse models of prostate cancer” Oncogene 18:5349-5355.
Slawin, K. (1993) “Dietary fenretinide, a synthetic retinoid, decreases the tumor incidene and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system” Cancer Research 53:4461-4465.
Supplementary Partial European Search Report from corresponding European patent application serial No. EP 02 76 9216.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Interstitial prostatism model animal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interstitial prostatism model animal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interstitial prostatism model animal will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4019122

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.